Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

15.4%

2 terminated/withdrawn out of 13 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 recruiting3 with results

Enrollment Performance

Analytics

N/A
12(100.0%)
12Total
N/A(12)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded